abemaciclib,ribociclib
eli lilly,novartis
['bcsm', 'natalee', 'verzenio', 'breast', 'monarche,(-monarcher)', ' ribo', 'monarche', 'ribociclib']
natalee trial shows that ribociclib decreases the risk of invasive tumor recurrence by 25% in early breast cancer.
difficult to compare to verzenio data from monarche, but good to have more options. #asco23
#bcsm 
Breast Oncologist at @MontefioreNYC @EinsteinMed. Interested in Translational Research & Clinical Trials. Diversity & Inclusion. On weekends 🚵🏾‍♂️
🇵🇪 🇺🇸